2008
DOI: 10.1007/978-3-211-75718-5_8
|View full text |Cite
|
Sign up to set email alerts
|

Bilirubin oxidation products (BOXes): synthesis, stability and chemical characteristics

Abstract: SummaryBilirubin oxidation products (BOXes) have been a subject of interest in neurosurgery because they are purported to be involved in subarachnoid hemorrhage induced cerebral vasospasm. There is a growing body of information concerning their putative role in vasospasm; however, there is a dearth of information concerning the chemical and biochemical characteristics of BOXes. A clearer understanding of the synthesis, stability and characteristics of BOXes will be important for a better understanding of the r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(26 citation statements)
references
References 49 publications
(93 reference statements)
1
25
0
Order By: Relevance
“…Ultraviolet light–exposed BOX salt solution (254 nm for 5 hours) was not effective in inducing vasoconstriction and converted the response to a nonsignificant increase in vascular diameter (5.8±3.5%; n=5 from 5 animals; P =0.14; 1‐way ANOVA; Figure 4 D), confirming that BOXes lose their biological activity by isomerization or degradation after illumination in the ultraviolet range. 12 , 15 In a next step of compound purification, we determined changes in arteriolar diameter after application of BOX extract (0.03 mg/mL), generated from the dried chloroform extract of the salt mixture. BOX extract induced a substantial decrease in vessel diameter by 31.5 ± 9.4% (n=5 from 4 animals; P <0.001; 1‐way ANOVA; Figure 4 D) within 15 minutes.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Ultraviolet light–exposed BOX salt solution (254 nm for 5 hours) was not effective in inducing vasoconstriction and converted the response to a nonsignificant increase in vascular diameter (5.8±3.5%; n=5 from 5 animals; P =0.14; 1‐way ANOVA; Figure 4 D), confirming that BOXes lose their biological activity by isomerization or degradation after illumination in the ultraviolet range. 12 , 15 In a next step of compound purification, we determined changes in arteriolar diameter after application of BOX extract (0.03 mg/mL), generated from the dried chloroform extract of the salt mixture. BOX extract induced a substantial decrease in vessel diameter by 31.5 ± 9.4% (n=5 from 4 animals; P <0.001; 1‐way ANOVA; Figure 4 D) within 15 minutes.…”
Section: Resultsmentioning
confidence: 99%
“…With the exception of the synthetic variant of the Z ‐isomer of BOX A ( Z ‐BOX A syn), all BOX‐containing compounds were prepared by the nonenzymatic oxidative degradation of bilirubin (Figure 3 A), modified after Wurster et al 15 Protected from light, 1 g of bilirubin was dissolved in 500 mL of 5 mol/L sodium hydroxide solution. The mixture was adjusted with 11 mol/L HCl to pH 7.5, and 50% hydrogen peroxide solution was added to a final concentration of 10% by volume.…”
Section: Methodsmentioning
confidence: 99%
“…In any case, due to the absence of sufficient purified compound, mole determinations were based upon a collective extinction coefficient (𝜀; 6,985 L/mol-cm -1 ) approximated using the absorption at 310 nm of a saline-reconstituted, chloroform extract of a hydrogen peroxide–bilirubin reaction mixture containing BOX A, BOX B, and MVM ( Wurster et al, 2008 ). Caveats associated with adoption of absorption at 310 nm include that there was some variability in the amounts of these BOXes species formed and, in particular, varied formation of MVM ( Wurster et al, 2008 ). This variability would influence the 𝜀 approximation because the λ max for MVM is 317 or 319 nm, at least as determined in methanol (as noted above; Bonnett and McDonagh, 1969 ; Kurtin, 1978 ).…”
Section: Endogenous Boxesmentioning
confidence: 99%
“…A second caveat associated with the approximated 𝜀 ( Wurster et al, 2008 ) is that the determination was based upon an estimated 50% conversion of bilirubin to BOXes by the hydrogen peroxide oxidation of bilirubin, with the remaining 50% unreacted bilirubin and biliverdin as well as “other compounds” that do not absorb at 310 nm ( Kranc et al, 2000 ; Pyne-Geithman et al, 2005 ; Wurster et al, 2008 ).…”
Section: Endogenous Boxesmentioning
confidence: 99%
“…In mammals most of the bilirubin is conjugated and excreted into the bile, but an additional oxidative degradation occurs. This ROS‐mediated breakdown leads to dipyrrolic propentdyopents (PDPs) and monopyrrolic bilirubin oxidation end products (BOXes, Scheme ) . BOX A and B exhibit an intact vinyl pyrrole and differ only in the position of vinyl and methyl group, whereas BOX C derives from the propionic acid pyrrole.…”
Section: Introductionmentioning
confidence: 99%